AlphaMissense: cataloging missense genetic mutations
It classified 89% of the 71 million possible missense variants: 32% as likely pathogenic and 57% as likely benign, with 90% precision on a database of known variants. Predictions are not intended for direct clinical use.
Technology: AlphaMissense
Family AlphaMissense: profile · models page
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: The model was validated on genetic and experimental benchmarks, and Genomics England cross-referenced its predictions with previously aggregated human variant pathogenicity data and found them consistent. The reported comparison uses previously collected pathogenicity and variant data; an independent data source is distinct from a new independent experimental replication.
- Still unknown: The model does not predict structural or stability effects, the blog says predictions are not designed for direct clinical use, and the abstract describes no clinical validation.
- AI role: AlphaMissense, an AlphaFold adaptation fine-tuned on human and primate variant population frequency data, classified missense variants and released predictions for all possible human substitutions.
Evidence sources: https://deepmind.google/blog/a-catalogue-of-genetic-mutations-to-help-pinpoint-the-cause-of-diseases/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1126/science.adg7492&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: blog. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 2381 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.